OncoSec Medical Announces YTD Results for Fiscal Year End 2014

OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the fiscal year ended July 31, 2014.



from Content Keyword RSS http://ift.tt/1rkHb4y

via IFTTT